Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.
Ontology highlight
ABSTRACT: Respiratory syncytial virus (RSV) represents a significant health threat to infants and to elderly or immunocompromised individuals. There are currently no vaccines available to prevent RSV infections, and disease management is largely limited to supportive care, making the identification and development of effective antiviral therapeutics against RSV a priority. To identify effective chemical scaffolds for managing RSV disease, we conducted a high-throughput anti-RSV screen of a 57,000-compound library. We identified a hit compound that specifically blocked activity of the RSV RNA-dependent RNA polymerase (RdRp) complex, initially with moderate low-micromolar potency. Mechanistic characterization in an in vitro RSV RdRp assay indicated that representatives of this compound class bl
SUBMITTER: Cox RM
PROVIDER: S-EPMC6204889 | biostudies-literature | 2018 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA